Leveraging Orphan Drugs for Lung Cancer Treatment
Read time: 4 minutes. As a dedicated researcher and oncologist, Noura Choudhury, MD, at the University of Chicago, witnesses daily the urgent need for better treatments for lung
Research Blogs
-
-
Careful Research Investments Yield Big Results
Read time: 3 minutes. When Erin Schenk, MD, PhD, began her journey as a junior faculty member at the University of Colorado, she treated patients with various types of lung cancer -
Conversations that Count: Geriatric Oncology & Engaging the Elderly in Cancer Care
Read time: 2 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts -
2025 ASCO: Highlights of Lung Cancer Research
Read time: 9 minutes. The annual meeting of the American Society of Clinical Oncology (ASCO) once again brought together nearly 50,000 members of the oncology community. From May -
Understanding DTPCs: A Path to Ending Drug Resistance in Lung Cancer
Read time: 2 minutes. When a person is treated for advanced-stage lung cancer, tumors will often shrink, and their symptoms may subside. An effective treatment will kill many tumor -
Committed to Cachexia: A Decade of LUNGevity Research
Read time: 4 minutes. As the nation’s leading lung cancer nonprofit and member of the Cancer Grand Challenges Cachexia Team, LUNGevity has been working to improve our understanding -
Sharing Experiences With EGFR Lung Cancer: A Tool Shaped by Patients and Caregivers
Read time: 3 minutes. Why did we build a tool to visualize data collected from patients and caregivers? Community members provide data but too often never see how their data was -
Conversations that Count: Lung Cancer Screening in Asian Americans
Read time: 4 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts -
A Future of Unifying Cancer Science and Medicine: Highlights from AACR 2025
Read time: 9 minutes. More than 22,000 cancer researchers from 81 countries got together for the annual American Association for Cancer Research (AACR) meeting in Chicago from -
The Overlooked Issues Faced by Women with Lung Cancer
Read time: 8 minutes. Narjust Florez, MD, is the associate director of the Cancer Care Equity Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center -
Conversations that Count: Using a Community Health Advisors Program to Address Cancer Disparities in the Deep South
Read time: 2 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts -
What Are Antibody-Drug Conjugates and How Do They Treat Lung Cancer?
Read time: 2 minutes. Historically, approaches to treating lung cancer included surgery, radiation, and chemotherapy. The past decade ushered in a new era of treatments with